A Behaviourally-Informed
Approach to
Equity Research
Cogentt Finance by Saili S Dalvi combines rigorous market research with an awareness of behavioural finance — research recommendations grounded in analysis, presented clearly so investors can apply their own independent judgement.
Meet Saili S Dalvi —
Your Research Analyst
I am a SEBI Registered Research Analyst (Registration No. INH000028653) based in Kalyan, Mumbai. My research process combines fundamental and technical market analysis with an awareness of behavioural finance — recognising that how an investor reads a recommendation matters as much as the recommendation itself.
Research is presented with clear rationale, risk factors, and disclosures, so that investors are equipped to apply their own independent judgement rather than act on a signal alone.
I specialize in equity research and technical analysis, offered strictly within the scope of SEBI (Research Analysts) Regulations, 2014.
Research Services
SEBI-registered equity research services, offered strictly within the scope of SEBI (Research Analysts) Regulations, 2014.
Stock Research & Recommendations
In-depth equity research covering fundamental analysis, valuation, and sector insights.
- Fundamental & valuation analysis
- Sector & industry deep-dives
- Buy / Hold / Sell recommendations
- Entry & exit price targets
- Risk assessment reports
Technical Analysis
Chart-based analysis using technical indicators to identify trends, reversals, and price levels.
- Chart pattern recognition
- Support & resistance levels
- Trend & momentum analysis
- Short & medium term setups
- Index & sector technicals
⚠️ Research services are offered strictly in accordance with SEBI (Research Analysts) Regulations, 2014, under Registration No. INH000028653. Recommendations are research opinions, not personalised investment advice — investors should apply independent judgement, or consult a SEBI-registered Investment Adviser for personalised advice, before acting.
Fee Structure
Fees for research services are governed by a signed client agreement and the Most Important Terms & Conditions (MITC), disclosed to every client before onboarding. As per SEBI norms, the maximum fee chargeable to an individual / HUF client (family of client) is capped at ₹1,51,000 per annum, exclusive of statutory levies such as GST — with no breakage fee for early termination. There is no guarantee of returns linked to fees paid, and no assured/guaranteed-return product is offered.
Research Analyst Lab
Learn how SEBI Research Analysts actually think — the methodology, not the market calls.
Research Analyst Lab is a monthly educational newsletter on equity research methodology and behavioural finance, written for investors who want to understand how professional research is done — not just what to buy or sell.
- How SEBI Research Analysts approach business & industry analysis
- Research methodologies — evaluating management quality, competitive positioning, capital allocation, and risk
- Behavioural finance concepts and investor psychology, explained in plain language
- Frameworks to help you read research more critically
- SEBI regulatory updates relevant to retail investors
What Makes Us Different
Behaviour-Aware Research
Research is presented with an awareness of behavioural finance principles, alongside fundamental and technical analysis.
Transparent & SEBI Compliant
All research follows SEBI (Research Analysts) Regulations, 2014. Every recommendation comes with clear rationale, risks, and disclosures.
Investor Education Focus
Recommendations are accompanied by the reasoning behind them, so investors can understand the "why" and "how" — not just the call.
Disclosed, Independent Research
Research is conducted independently, with conflicts of interest disclosed as required under SEBI regulations.
Mumbai-Based, India-Focused
Grounded in Indian markets and the regulatory environment relevant to Indian retail investors.
Our Research Process
Research Universe Selection
Securities are selected for research coverage based on liquidity, sector relevance, and fundamental characteristics.
Behavioural Considerations in Research
Our research process is informed by an awareness of common cognitive biases that affect investment decisions, so that recommendations are presented in a way investors can evaluate rationally.
Deep Research & Analysis
Comprehensive fundamental and technical analysis of securities, including financial statement analysis, industry study, and valuation.
Research Report & Recommendation
A research report with clear rationale, target price, stop loss, risk factors, and SEBI-mandated disclosures — explained in plain language.
Ongoing Monitoring & Updates
Markets change. Recommendations under coverage are monitored on an ongoing basis, with updates issued as required.
Important Regulatory Disclaimer
SEBI Registration: Saili S Dalvi is a SEBI Registered Research Analyst under SEBI (Research Analysts) Regulations, 2014, Registration No. INH000028653. Registration with SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Nature of Services: Cogentt Finance offers equity research and technical analysis services strictly within the scope permitted to a SEBI Registered Research Analyst. We do not provide mutual fund advisory, portfolio management, financial planning, insurance advisory, or any form of personalised investment advice. Investors seeking personalised advice should consult a SEBI-registered Investment Adviser.
Not Personalised Advice: Research reports and recommendations published on this website are research opinions on securities and are general in nature. They do not take into account the individual financial situation, objectives, or risk appetite of any specific investor. Investors should apply their own independent judgement, and are advised to read the research report / recommendation in its entirety, including the disclosures, before acting on it.
Investment Risk: Investments in securities markets are subject to market risks. Past performance is not indicative of future results. Please read all related documents carefully before investing. There is no guarantee or assurance of returns.
Grievance Redressal / Escalation Matrix:
Level 1 — Contact the Proprietor: For any grievance or complaint, please reach out directly.
Name: Saili S Dalvi
Email: cogenttfinance@gmail.com
Mobile: +91-9930121608
Office Address: Kalyan, Mumbai, Maharashtra, India
Level 2 — SCORES: If not satisfied with the response at Level 1, the client may lodge a complaint on SEBI's SCORES platform: scores.sebi.gov.in.
Level 3 — SMART ODR: If the matter still remains unresolved, it can be taken up through the SMART Online Dispute Resolution (ODR) platform for online conciliation/arbitration: smartodr.in.
Investor Charter & Do's and Don'ts: The SEBI Investor Charter for Research Analysts, including the Do's and Don'ts for investors, is displayed in full below and is shared with every client during onboarding, along with the Most Important Terms and Conditions (MITC) governing the scope of services, fees, and grievance process.
Investor Charter for Research Analysts
As prescribed by SEBI (Master Circular for Research Analysts dated February 06, 2026, Annexure D). A copy is also provided to every client during onboarding.
A. Vision and Mission Statements for investors
Vision: Invest with knowledge & safety.
Mission: Every investor should be able to invest in right investment products based on their needs, manage and monitor them to meet their goals, access reports and enjoy financial wellness.
B. Details of business transacted by the Research Analyst with respect to the investors
- To publish research report based on the research activities of the RA.
- To provide an independent unbiased view on securities.
- To offer unbiased recommendation, disclosing the financial interests in recommended securities.
- To provide research recommendation, based on analysis of publicly available information and known observations.
- To conduct audit annually.
- To ensure that all advertisements are in adherence to the provisions of the Advertisement Code for Research Analysts.
- To maintain records of interactions, with all clients including prospective clients (prior to onboarding), where any conversation related to the research services has taken place.
C. Details of services provided to investors (No Indicative Timelines)
Onboarding of Clients
- Sharing of terms and conditions of research services
- Completing KYC of fee paying clients
Disclosure to Clients
- To disclose, information that is material for the client to make an informed decision, including details of its business activity, disciplinary history, the terms and conditions of research services, details of associates, risks and conflicts of interest, if any
- To disclose the extent of use of Artificial Intelligence tools in providing research services
- To disclose, while distributing a third party research report, any material conflict of interest of such third party research provider or provide web address that directs a recipient to the relevant disclosures
- To disclose any conflict of interest of the activities of providing research services with other activities of the research analyst.
- To distribute research reports and recommendations to the clients without discrimination.
- To maintain confidentiality w.r.t publication of the research report until made available in the public domain.
- To respect data privacy rights of clients and take measures to protect unauthorized use of their confidential information.
- To disclose the timelines for the services provided by the research analyst to clients and ensure adherence to the said timelines.
- To provide clear guidance and adequate caution notice to clients when providing recommendations for dealing in complex and high-risk financial products/services.
- To treat all clients with honesty and integrity.
- To ensure confidentiality of information shared by clients unless such information is required to be provided in furtherance of discharging legal obligations or a client has provided specific consent to share such information.
D. Details of grievance redressal mechanism and how to access it
1. An investor can lodge a complaint/grievance against the Research Analyst in the following ways:
Mode of filing the complaint with the research analyst: In case of any grievance / complaint, an investor may approach the concerned Research Analyst who shall strive to redress the grievance immediately, but not later than 21 days of the receipt of the grievance.
Mode of filing the complaint on SCORES or with Research Analyst Administration and Supervisory Body (RAASB):
- SCORES 2.0 (a web based centralized grievance redressal system of SEBI for facilitating effective grievance redressal in time-bound manner) — scores.sebi.gov.in. Two level review for complaint/grievance against Research Analyst: first review done by designated body (RAASB), second review done by SEBI.
- Email to designated email ID of RAASB.
2. If the investor is not satisfied with the resolution provided by the Market Participants, the investor has the option to file the complaint/grievance on the SMART ODR platform (smartodr.in) for its resolution through online conciliation or arbitration.
With regard to physical complaints, investors may send their complaints to: Office of Investor Assistance and Education, Securities and Exchange Board of India, SEBI Bhavan, Plot No. C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.
E. Rights of investors
- Right to Privacy and Confidentiality
- Right to Transparent Practices
- Right to fair and Equitable Treatment
- Right to Adequate Information
- Right to Initial and Continuing Disclosure — right to receive information about all the statutory and regulatory disclosures
- Right to Fair & True Advertisement
- Right to Awareness about Service Parameters and Turnaround Times
- Right to be informed of the timelines for each service
- Right to be Heard and Satisfactory Grievance Redressal
- Right to have timely redressal
- Right to Exit from Financial product or service in accordance with the terms and conditions agreed with the research analyst
- Right to receive clear guidance and caution notice when dealing in Complex and High-Risk Financial Products and Services
- Additional Rights to vulnerable consumers — right to get access to services in a suitable manner even if differently abled
- Right to provide feedback on the financial products and services used
- Right against coercive, unfair, and one-sided clauses in financial agreements
F. Expectations from the investors (Responsibilities of investors)
Do’s
- Always deal with SEBI registered Research Analyst.
- Ensure that the Research Analyst has a valid registration certificate.
- Check for SEBI registration number. The list of all SEBI registered Research Analysts is available on the SEBI website: SEBI list of Research Analysts.
- Always pay attention towards disclosures made in the research reports before investing.
- Pay your Research Analyst through banking channels only and maintain duly signed receipts mentioning the details of your payments. You may make payment of fees through Centralized Fee Collection Mechanism (CeFCoM) of RAASB if research analyst has opted for the mechanism. (Applicable for fee paying clients only)
- Before buying/ selling securities or applying in public offer, check for the research recommendation provided by your Research Analyst.
- Ask all relevant questions and clear your doubts with your Research Analyst before acting on recommendation.
- Seek clarifications and guidance on research recommendations from your Research Analyst, especially if it involves complex and high risk financial products and services.
- Always be aware that you have the right to stop availing the service of a Research Analyst as per the terms of service agreed between you and your Research Analyst.
- Always be aware that you have the right to provide feedback to your Research Analyst in respect of the services received.
- Always be aware that you will not be bound by any clause, prescribed by the research analyst, which is contravening any regulatory provisions.
- Inform SEBI about Research Analyst offering assured or guaranteed returns.
Don’ts
- Do not provide funds for investment to the Research Analyst.
- Don’t fall prey to luring advertisements or market rumors.
- Do not get attracted to limited period discount or other incentive, gifts, etc. offered by Research Analyst.
- Do not share login credential and password of your trading, demat or bank accounts with the Research Analyst.
No Execution of Trades: As a Research Analyst, Cogentt Finance / Saili S Dalvi does not execute or carry out any purchase or sale transaction on behalf of clients. All investment decisions and their execution remain solely with the investor.
Investor Complaints Data (Monthly Disclosure): As required under SEBI's Master Circular for Research Analysts (format as per Annexure E), complaint data received against Cogentt Finance / Saili S Dalvi and its redressal status is disclosed below and updated by the 7th of every succeeding month.
| Sr. No. | Received from | Pending at the end of last month | Received | Resolved* | Total Pending# | Pending complaints > 3 months | Average Resolution time^ (in days) |
|---|---|---|---|---|---|---|---|
| 1 | Directly from Investors | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | SEBI (SCORES) | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | Other Sources (if any) | 0 | 0 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | 0 | 0 | |
Number of complaints received during the month against the RA due to impersonation by some other entity: 0
*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month. ^Average Resolution time is the sum total of time taken to resolve each complaint, in days, in the current month divided by total number of complaints resolved in the current month.
| Sr. No. | Month | Carried forward from previous month | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | July 2026 | 0 | 0 | 0 | 0 |
| 2 | August 2026 | 0 | 0 | 0 | 0 |
| 3 | September 2026 | 0 | 0 | 0 | 0 |
| 4 | October 2026 | — | — | — | — |
| 5 | November 2026 | — | — | — | — |
| 6 | December 2026 | — | — | — | — |
| 7 | January 2027 | — | — | — | — |
| 8 | February 2027 | — | — | — | — |
| 9 | March 2027 | — | — | — | — |
| Grand Total | — | 0 | 0 | 0 | |
*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.
| Sr. No. | Year | Carried forward from previous year | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | 2026-27 (from July 1, 2026; year in progress) | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | |
*Inclusive of complaints of previous years resolved in the current year. #Inclusive of complaints pending as on the last day of the year. No investor complaints have been received to date. This disclosure is updated by the 7th of every succeeding month. Last updated: October 9, 2026.
Contact for Disclosures: For full regulatory disclosures, conflict of interest statements, MITC, and compliance documents, please contact us directly at the details provided in the Contact section.
Get in Touch
Have questions about our research services? Reach out — we'd love to hear from you.